We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$289B
AUM Growth
+$17B
Cap. Flow
+$19B
Cap. Flow %
6.57%
Top 10 Hldgs %
11.8%
Holding
7,065
New
213
Increased
3,439
Reduced
2,832
Closed
120
Avg Time Held
6.7 quarters
Top 10 Avg Time Held
5 quarters
Top 20 Avg Time Held
5.7 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.23%
2 Healthcare 10.87%
3 Financials 9.03%
4 Technology 8.57%
5 Consumer Discretionary 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SSBI icon
6326
Summit State Bank
SSBI
$82.7M
$2K ﹤0.01%
260
-67
-20% -$650
2013 Q4
6 quarters
ULBI icon
6327
Ultralife
ULBI
$104M
$2K ﹤0.01%
530
+1
+0.2% +$4
2013 Q4
6 quarters
QVCGB
6328
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$2K ﹤0.01%
1
– –
2014 Q1
5 quarters
GGE icon
6329
DELISTED
Green Giant Inc. Common Stock
GGE
$2K ﹤0.01%
489
-8,608
-95% -$50.9K
2013 Q4
6 quarters
SOFO
6330
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$2K ﹤0.01%
198
+101
+104% +$846
2014 Q1
5 quarters
ACER
6331
DELISTED
Acer Therapeutics Inc
ACER
$2K ﹤0.01%
48
– –
2013 Q4
6 quarters
CYTO icon
6332
DELISTED
Altamira Therapeutics Ltd
CYTO
– –
0
– –
2014 Q3
3 quarters
WBII
6333
DELISTED
WBI BullBear Global Income ETF
WBII
$2K ﹤0.01%
+83
New +$2.12K
2015 Q2
0 quarters
AXU
6334
DELISTED
Alexco Resource Corp
AXU
$2K ﹤0.01%
7,310
-5,000
-41% -$2.04K
2013 Q2
8 quarters
ICBK
6335
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$2K ﹤0.01%
111
+2
+2% +$40
2015 Q1
1 quarter
UCI
6336
DELISTED
E-TRACS UBS Bloomberg CMCI ETN
UCI
$2K ﹤0.01%
112
– –
2013 Q4
6 quarters
UBIO
6337
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
$2K ﹤0.01%
+17
New +$1.57K
2015 Q2
0 quarters
TAX icon
6338
DELISTED
Liberty Tax, Inc. Class A
TAX
$2K ﹤0.01%
63
-12,940
-100% -$326K
2013 Q4
6 quarters
FSNN
6339
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$2K ﹤0.01%
676
+2
+0.3% +$10
2014 Q2
4 quarters
ONVI
6340
DELISTED
Onvia, Inc.
ONVI
$2K ﹤0.01%
514
+2
+0.4% +$9
2013 Q4
6 quarters
HVPW
6341
DELISTED
U.S. Equity High Volatility Put Write Index Fund
HVPW
$2K ﹤0.01%
70
– –
2015 Q1
1 quarter
TEUM
6342
DELISTED
Pareteum Corporation
TEUM
$2K ﹤0.01%
181
-133
-42% -$1.33K
2013 Q4
6 quarters
ESMC
6343
DELISTED
Escalon Medical Corp
ESMC
$2K ﹤0.01%
1,014
+1
+0.1% +$1
2013 Q4
6 quarters
MGT
6344
DELISTED
MGT CAPITAL INVESTMENTS INC COM NEW (DE)
MGT
$2K ﹤0.01%
3,960
– –
2014 Q3
3 quarters
PVCT
6345
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$2K ﹤0.01%
3,500
– –
2014 Q2
4 quarters
ECTE
6346
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$2K ﹤0.01%
1,420
-4,380
-76% -$7.32K
2013 Q3
7 quarters
RRM
6347
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
$2K ﹤0.01%
280
+1
+0.4% +$7
2013 Q4
6 quarters
RLJE
6348
DELISTED
RLJ Entertainment, Inc.
RLJE
$2K ﹤0.01%
1,255
+1
+0.1% +$2
2014 Q1
5 quarters
RGSE
6349
DELISTED
Real Goods Solar, Inc. Class A
RGSE
$2K ﹤0.01%
+1
New +$2.11K
2015 Q2
0 quarters
ATE
6350
DELISTED
Advantest Corp
ATE
$2K ﹤0.01%
190
– –
2013 Q4
6 quarters

Similar funds

Morgan Stanley's Q2 2015 Portfolio in Review

As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.

  • Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
  • Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
  • Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
  • Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
  • Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
  • Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
  • Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.

Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.